Nonspecific down-regulation of CD8+ T-cell responses in mice expressing human papillomavirus type 16 E7 oncoprotein from the keratin-14 promoter

Journal of Virology

Volumn 75, Issue 13, 2001, Pages 5985-5997

  Tindle, R W ^a   Herd, K ^a   Doan, T ^a   Bryson, G ^a   Leggatt, G R ^a   Lambert, P ^a   Frazer, I H ^a   Street, M ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; KERATIN; ONCOPROTEIN; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; CYTOTOXIC T LYMPHOCYTE; DOWN REGULATION; IMMUNIZATION; IMMUNOMODULATION; KERATINOCYTE; MAJOR HISTOCOMPATIBILITY COMPLEX; MEMORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DENSITY; T LYMPHOCYTE; THYMUS; TUMOR GROWTH; UTERINE CERVIX CARCINOMA; WART VIRUS;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; DOWN-REGULATION; FEMALE; HUMANS; IMMUNIZATION; IMMUNOLOGIC MEMORY; KERATIN-14; KERATINS; MICE; ONCOGENE PROTEINS, VIRAL; PROMOTER REGIONS (GENETICS); RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTES, CYTOTOXIC; UTERINE CERVICAL NEOPLASMS;

EID: 0034968467     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.13.5985-5997.2001     Document Type: Article

References (45)

1. Thymic dendritic cells express inducible nitric oxide synthase and generate nitric oxide in response to self- and alloantigens
2. Selective expansion of high- and low-avidity cytotoxic T lymphocytes and efficacy, for adoptive immunotherapy
3. Differential expansion and survival of high and low avidity cytotoxic T cell populations during the immune response to a viral infection
4. Chronic modulation of the TCR repertoire in the lymphoid periphery
5. A role for endogenous transforming growth factor beta 1 in Langerhans cell biology: The skin of transforming growth factor beta 1 null mice is devoid of epidermal Langerhans cells
6. A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer
7. Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunization
8. Self-tolerance to the murine homologue of a tyrosinase-derived melanoma antigen: Implications for tumor immunotherapy
9. Critical role for CD8 in T cell receptor binding and activation by peptide/major histocompatibility complex multimers
10. Tracing and characterization of the low-avidity self-specific T cell repertoire
11. HPV 16 E7 antibody levels in cervical cancer patients: Before and after treatment
12. Mice expressing the E7 oncogene of HPV16 in epithelium show central tolerance, and evidence of peripheral anergising tolerance, to E7-encoded cytotoxic T-lymphocyte epitopes
13. Human papillomavirus type 16 E7 oncoprotein expressed in peripheral epithelium tolerizes E7-directed cytotoxic T-lymphocyte precursors restricted through human (and mouse) major histocompatibility complex class I alleles
14. Peripheral tolerance to human papillomavirus E7 oncoprotein occurs by cross-tolerization, is largely Th-2-independent, and is broken by dendritic cell immunization
15. Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells
16. Levels of peripheral T cell tolerance induced by different doses of tolerogen
17. Th2-type CD4+ cells neither enhance nor suppress antitumor CTL activity in a mouse tumor model
18. Effect of iscoms and their adjuvant moiety (matrix) on the initial proliferation and IL-2 responses: Comparison of spleen cells from mice inoculated with iscoms and/or matrix
19. Split tolerance to a viral antigen expressed in thymic epithelium and keratinocytes
20. The avidity spectrum of T cell receptor interactions accounts for T cell energy in a double transgenic model
21. Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2
22. Squamous epithelial hyperplasia and carcinoma in mice transgenic for the human papillomavirus type 16 E7 oncogene
23. The use of HLA A2.1/p53 peptide tetramers to visualize the impact of self tolerance on the TCR repertoire
24. Lymphoproliferative responses to human papillomavirus (HPV) type 16 proteins E6 and E7: Outcome of HPV infection and associated neoplasia
25. CD4+ T cell help impairs CD8+ T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity
26. Unopposed positive selection and autoreactivity in mice expressing class II MHC only on thymic cortex
27. HPV-16 E7 but not E6 oncogenic protein triggers both cellular immunosuppression and angiogenic processes
28. Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen
29. Receptor editing in developing T cells
30. Peripheral T-cell tolerance
31. Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection
32. Anti-tumour immunotherapy with synthetic peptides representing turnout associated T-cell epitopes: Implications for peptide based vaccination of cervical cancer
33. Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptides
34. Occasional memory cytotoxic T-cell responses of patients with human papillomavirus type 16-positive cervical lesions against a human leukocyte antigen-A*0201-restricted E7-encoded epitope
35. Monocyte-derived IL-10-secreting dendritic cells in choroid plexus epithelium
36. Incomplete CDS(+) T lymphocyte differentiation as a mechanism for subdominant cytotoxic T lymphocyte responses to a viral antigen
37. The induction of tolerance by dendritic cells that have captured apoptotic cells
38. A subclass of dendritic cells kills CD4 T cells via Fas/Fas-figand-induced apoptosis
39. Tolerance to p53 by A2.1-restricted cytotoxic T lymphocytes
40. Anergic T cells inhibit the antigen-presenting function of dendritic cells
41. Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex
42. Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: Consequences for the phenotype and E6-p53 and E7-pRB interactions
43. Constitutive expression of B7-1 (CD80) on mouse keratinocytes does not prevent development of chemically induced skin papillomas and carcinomas
44. Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers
45. High avidity, CTLs for two self-antigens demonstrate superior in vitro and in vivo antitumor efficacy